Food News and Research

RSS

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) today announced top-line results indicating the company's two pivotal Phase III clinical trials evaluating the efficacy and safety of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome (IBS-d) met both the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) formally agreed-upon primary endpoints of composite response based on simultaneous improvements in stool consistency and abdominal pain.

4 Feb 2014

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

A group of prominent healthcare experts including bioethicists, pharmacists, policymakers and cancer specialists have proposed concrete steps for preventing and managing a nightmare scenario that is becoming all too common: shortages of life-saving drugs.

4 Feb 2014

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Pfizer Inc. today announced that the randomized Phase 2 trial [PALOMA-1] of palbociclib achieved its primary endpoint by demonstrating a statistically significant and clinically meaningful improvement in progression-free survival (PFS) for the combination of palbociclib and letrozole compared with letrozole alone in post-menopausal women with estrogen receptor positive (ER+), human epidermal growth factor receptor 2 negative (HER2-) locally advanced or newly diagnosed metastatic breast cancer.

4 Feb 2014

Edison's vatiquinone receives Orphan Status for treatment of Friedreich's ataxia

Edison Pharmaceuticals today announced that the US Food and Drug Administration has granted Orphan Status to vatiquinone for the treatment of Friedreich's ataxia.

4 Feb 2014

High sodium intake correlates with fatness and inflammation in adolescents

Most adolescents consume as much salt as adults - some more than twice the recommended daily allowance - and that high sodium intake correlates with fatness and inflammation regardless of how many calories they consume, researchers report.

3 Feb 2014

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

Ligand Pharmaceuticals Incorporated today announced that the U.S. Food and Drug Administration has granted its partner GlaxoSmithKline plc Breakthrough Therapy designation for Promacta/Revolade (eltrombopag) for the treatment of cytopenias in patients with severe aplastic anemia (SAA) who have had insufficient response to immunosuppressive therapy.

3 Feb 2014

Five important numbers to keep cardiovascular system healthy

Pass codes, phone numbers, social security numbers, clothing sizes and addresses. We all have a lot of numbers in our heads, but heart experts at The Ohio State University Wexner Medical Center say there are five more you need to know to help keep your cardiovascular system healthy.

3 Feb 2014

Controlling fast food consumption could reverse epidemic of obesity

Governments could slow - and even reverse - the growing epidemic of obesity by taking measures to counter fast food consumption, according to a study published in the Bulletin of the World Health Organization today.

3 Feb 2014

Researchers find liver tumors in mice exposed to BPA during gestation and nursing

In one of the first studies to show a significant association between BPA and cancer development, University of Michigan School of Public Health researchers have found liver tumors in mice exposed to the chemical via their mothers during gestation and nursing.

3 Feb 2014

Weight rhythms: Weight increases during weekends and decreases during weekdays

There are sleep cycles and there are also weight loss cycles. Almost everyone loses weight on weekdays and gains weight on weekends. What separates the slim from the heavy isn't how much more they gain on weekends.

3 Feb 2014

Onset Dermatologics announces nationwide availability of Tretin-X Cream 0.075%

Onset Dermatologics, LLC, a leader in developing and commercializing prescription products for improving skin health, announced the nationwide availability of Tretin-X (tretinoin, USP) Cream 0.075%. Tretin-X Cream is a prescription product for the topical treatment of acne.

31 Jan 2014

Treating peanut allergy with oral immunotherapy changes DNA of immune cells

Treating a peanut allergy with oral immunotherapy changes the DNA of the patient's immune cells, according to a new study from the Stanford University School of Medicine and Lucile Packard Children's Hospital Stanford. The DNA change could serve as the basis for a simple blood test to monitor the long-term effectiveness of the allergy therapy.

31 Jan 2014

New study reveals way to combat drug-resistant tumors

Cancer drugs that recruit antibodies from the body's own immune system to help kill tumors have shown much promise in treating several types of cancer. However, after initial success, the tumors often return.

31 Jan 2014

Beaumont Health System use new balloon ablation technology to treat atrial fibrillation

Beaumont Health System is the first center outside of Japan to use a new balloon ablation technology to treat atrial fibrillation, the most common heart rhythm disorder that affects about 3 million people in the U.S.

31 Jan 2014

Vanda Pharmaceuticals announces FDA approval of HETLIOZ for Non-24 treatment

Vanda Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration has approved HETLIOZ (tasimelteon) 20mg capsules for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24). HETLIOZ is the first FDA approved medication for Non-24.

31 Jan 2014

Researchers develop antibiotic "smart bomb" that can identify specific strains of bacteria

Researchers from North Carolina State University have developed a de facto antibiotic "smart bomb" that can identify specific strains of bacteria and sever their DNA, eliminating the infection. The technique offers a potential approach to treat infections by multi-drug resistant bacteria.

31 Jan 2014

Children with peanut allergies could benefit from oral immunotherapy treatment

Children and adolescents with peanut allergies could benefit from treatment with oral immunotherapy (OIT), in which peanut protein is consumed in increasingly larger amounts on a regular basis to build up tolerance, according to a phase 2 trial published in The Lancet.

31 Jan 2014

Large amounts of choline may be needed to support fetal development during pregnancy

Recent research published in the American Journal of Clinical Nutrition found that during pregnancy, and particularly during the third trimester, large amounts of choline may be needed to support fetal development. Conclusions of the research revealed that current recommendations may be too low. Choline deficiency in pregnant women may result in elevated levels of homocysteine, potentially resulting in birth defects.

31 Jan 2014

Biologists open new window on natural process of bone regeneration in zebra fish

University of Oregon biologists say they have opened the window on the natural process of bone regeneration in zebra fish, and that the insights they gained could be used to advance therapies for bone fractures and disease.

30 Jan 2014

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2013. For the three months ended December 31, 2013, Alexion Pharmaceuticals, Inc. ("Alexion" or the "Company") reported net product sales of Soliris® (eculizumab) of $441.9 million, compared to $320.5 million for the same period in 2012.

30 Jan 2014

Food News and Research

Furiex announces top-line results of Phase III clinical trials of eluxadoline in treatment of IBS-d

Healthcare experts propose concrete steps for managing shortages of life-saving drugs

Pfizer’s palbociclib Phase 2 trial achieves primary endpoint in patients with advanced breast cancer

Edison's vatiquinone receives Orphan Status for treatment of Friedreich's ataxia

High sodium intake correlates with fatness and inflammation in adolescents

FDA grants Breakthrough Therapy designation to GSK's Promacta/Revolade for treatment of cytopenias

Five important numbers to keep cardiovascular system healthy

Controlling fast food consumption could reverse epidemic of obesity

Researchers find liver tumors in mice exposed to BPA during gestation and nursing

Weight rhythms: Weight increases during weekends and decreases during weekdays

Onset Dermatologics announces nationwide availability of Tretin-X Cream 0.075%

Treating peanut allergy with oral immunotherapy changes DNA of immune cells

New study reveals way to combat drug-resistant tumors

Beaumont Health System use new balloon ablation technology to treat atrial fibrillation

Vanda Pharmaceuticals announces FDA approval of HETLIOZ for Non-24 treatment

Researchers develop antibiotic "smart bomb" that can identify specific strains of bacteria

Children with peanut allergies could benefit from oral immunotherapy treatment

Large amounts of choline may be needed to support fetal development during pregnancy

Biologists open new window on natural process of bone regeneration in zebra fish

Alexion Pharmaceuticals reports full year 2013 GAAP and non-GAAP financial results

Understanding cultivated meat and its global potential eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News